Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use. [electronic resource]
- The journal of allergy and clinical immunology. In practice 05 2020
- 1616-1624 p. digital
Publication Type: Journal Article
2213-2201
10.1016/j.jaip.2019.12.037 doi
Adrenal Cortex Hormones--therapeutic use Anti-Asthmatic Agents--therapeutic use Asthma--drug therapy Biological Products--therapeutic use Humans Quality of Life